Latest 2024 US State E-Cigarette Index: Policy Impact Analysis

Oct.17.2024
Latest 2024 US State E-Cigarette Index: Policy Impact Analysis
Consumer Choice Center released the 2024 US State E-Cigarette Index, with Alaska, North Dakota, and Tennessee earning the highest grades.

Recently, the official website of the Consumer Choice Center in the United States released the latest 2024 edition of the e-cigarette index for each state, evaluating all 50 states and the District of Columbia. The data shows that only Alaska, North Dakota, and Tennessee received an A+ rating for their evidence-based e-cigarette policy approaches in the study.


This rating indicates that these states are able to use e-cigarettes as harm reduction tools while still allowing consumers to make their own choices. Other states that have performed well include Arizona, Michigan, Mississippi, Missouri, Montana, Texas, Alabama, Arkansas, Oklahoma, and Wisconsin.


On the contrary, 12 states like Utah (0 points), California (5 points), and Vermont (10 points) have implemented restrictive policies on e-cigarettes. These states include Oregon, New York, New Jersey, Nebraska, Massachusetts, Illinois, Hawaii, Washington D.C., and Colorado (all scored 15 points).


Since the first edition of the index in 2020, the number of states with low scores has doubled.


Consumer Choice Center research director Emil Panzaru stated,


E-cigarettes have the potential to save lives. If all smokers in the United States switched to e-cigarettes within the next ten years, it could prevent 6.6 million premature deaths.


However, policymakers have failed to recognize that e-cigarettes are an effective alternative to traditional combustible tobacco products and have mistakenly treated e-cigarettes as tobacco products. They have implemented strict flavor bans, increased taxes, mandatory product registration, and online sales bans on e-cigarettes. These policies have made it difficult for consumers to break more harmful smoking habits and have fueled the black market for e-cigarettes. Ultimately, this has led to state laws conflicting with the latest global public health practices.


The index measures five factors: whether states classify e-cigarettes as tobacco products, state-level restrictions on e-cigarette flavors, state registration requirements, additional e-cigarette taxes, and the presence of online sales bans.


Pan Zalu stated,


The most reliable studies, such as those confirmed by authoritative institutions such as Public Health England, indicate that e-cigarettes are 95% safer than combustible tobacco for users. Evidence from the New England Journal of Medicine shows that e-cigarettes are twice as effective as any nicotine patch, gum, or spray in helping people quit smoking. Furthermore, a review of 15 different studies found little to no evidence of a gateway effect of e-cigarettes leading young people to smoking or other hard drugs.


State authorities should carefully study the example of Sweden, which is the first European country to become smoke-free through evidence-driven tools for harm reduction, rather than adopting inappropriate policies ignoring evidence.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore will maintain etomidate’s classification under drug control laws while preparing new legislation targeting e-vaporisers, as authorities reinforce a hardline regulatory stance on vaping.
Feb.05
Exclusive|Suspected China Tobacco Nicotine Oral Film Product Surfaces on Social Media
Exclusive|Suspected China Tobacco Nicotine Oral Film Product Surfaces on Social Media
China Tobacco Jiangsu IC appears to have developed a nicotine oral film product under the "Nanjing" brand, according to images circulating on Chinese social media. If confirmed, this could potentially mark China Tobacco's first oral nicotine product targeting the domestic market. The product's authenticity has not been officially verified, and no nicotine pouch products have been approved for sale in China.
Feb.09
2Firsts’ Nine Global Turning Points: How 2025 Reshaped the Nicotine Industry
2Firsts’ Nine Global Turning Points: How 2025 Reshaped the Nicotine Industry
In 2025, the global nicotine industry reached a critical turning point. Regulatory realignment, category shifts, capital repositioning and technological intervention unfolded in parallel, loosening old structures while new ones took shape. 2Firsts reviews nine pivotal events that reshaped the industry’s trajectory.
Jan.14
Philippine FDA Requires Licenses for Vape Products with Medical Claims
Philippine FDA Requires Licenses for Vape Products with Medical Claims
The Philippine Food and Drug Administration has announced that establishments selling vaporized nicotine and non-nicotine products and novel tobacco products with medicinal or therapeutic claims must secure Licenses to Operate. Such products are also required to be registered as pharmaceutical products through the Center for Drug Regulation and Research. The FDA urged stakeholders to comply with the new requirements to ensure product safety, efficacy and quality.
Dec.22 by 2FIRSTS.ai
Altria Reports Full-Year 2025 Results: Revenue Down 3.1%, Cigarette Volumes Slide 10% as NJOY Takes Impairment Hit
Altria Reports Full-Year 2025 Results: Revenue Down 3.1%, Cigarette Volumes Slide 10% as NJOY Takes Impairment Hit
Altria has released its full-year 2025 results, reporting full-year net revenues of $23.279 billion, down 3.1% year over year. Domestic cigarette shipment volume fell 10% for the year. on! nicotine pouches reached a 7.7% share of the U.S. oral tobacco category in the fourth quarter. NJOY posted $21 million in net revenues in Q4, while full-year net revenues were negative $13 million (mainly due to returns and related factors).
Jan.30 by 2FIRSTS.ai
Russia considers digital tagging for e-cigarette products to strengthen industry regulation
Russia considers digital tagging for e-cigarette products to strengthen industry regulation
Russia is considering digitizing e-cigarette products for better industry regulation, aiming to protect consumers and prevent counterfeit products.
Feb.05 by 2FIRSTS.ai